Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of Ciclesonide HFA Nasal Aerosol in Seasonal Allergic Rhinitis
NCT00790023Phase 3Completed
- Sponsor
- Sumitomo Pharma America
- Start
- Nov 2008
- Primary completion
- Feb 2009
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of ciclesonide in seasonal allergic rhinitis (SAR), sponsored by Sumitomo Pharma America. Started Nov 2008; status: completed.
02
Drugs
ciclesonide
03
Conditions
seasonal allergic rhinitis (SAR)
Beyond the preview
Go deeper on NCT00790023.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00790023.